| |
|
|
|
Rockwell Medical In
|
|
6.93 -0.16 (-2.26%) |
10/17/2017 4:00pm |
|
Open: |
7.09 |
Pre close: |
7.09 |
Target:
|
8.97
|
|
High: |
7.25 |
Low: |
6.91 |
Resistance:
|
7.68
8.70
|
|
Volume: |
217,592 |
Market Cap: |
358.56M |
Support:
|
6.02
5.01
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.06
 |
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
7.50  |
Signal(12,26,9): |
0.16 |
|
MA(100): |
7.23 |
Stochastic Oscillator |
%K(14,3):
|
3.51 |
|
MA(250): |
6.72 |
%D(3): |
8.50 |
|
Average Volume(K) |
3-Month: |
19900
|
52-Week |
High:
|
8.98 |
|
10-Days: |
12850 |
Low: |
3.55 |
|
RSI |
RSI(14):
|
43.23 |
Change(%): |
16.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.420 |
Return on Equity (ttm) |
-42.3 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-0.440 |
Return on Assets (ttm) |
-17.3 |
Shares Float (M) |
46.53 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
-0.80 |
% Held by Insiders |
9.69 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
-1.6 |
% Held by Institutions |
32.09 |
|
Forward EPS |
-0.280 |
Gross Profit (p.s.) |
0.130 |
Shares Short (K) |
8200 |
|
Book Value (p.s.) |
0.850 |
EBITDA (p.s.) |
-0.407 |
P/E |
-16.50 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.15 |
|
Profit Margin |
-39.68 |
Operating Cash Flow
(M) |
-18.41 |
P/S |
338262464.00 |
|
Operating Margin |
-40.14 |
Levered Free Cash Flow
(M) |
-6.48 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
